Acquisition by Cambrian Biopharma Inc of 19000 shares of Sensei Biotherapeutics at 0.709 subject to Rule 16b-3
| SPLM Stock | USD 0.0001 0.00 0.00% |
About 56% of Sentry Petroleum's investor base is looking to short. The analysis of overall sentiment of trading Sentry Petroleum stock suggests that many investors are alarmed at this time. Sentry Petroleum's investing sentiment overview a quick insight into current market opportunities from investing in Sentry Petroleum. Many technical investors use Sentry Petroleum stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sentry |
Filed transaction by Sensei Biotherapeutics 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Sentry Petroleum's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Sentry Petroleum's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Sentry Petroleum Fundamental Analysis
We analyze Sentry Petroleum's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sentry Petroleum using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sentry Petroleum based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Sentry Petroleum is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Sentry Petroleum Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sentry Petroleum stock to make a market-neutral strategy. Peer analysis of Sentry Petroleum could also be used in its relative valuation, which is a method of valuing Sentry Petroleum by comparing valuation metrics with similar companies.
Peers
Sentry Petroleum Related Equities
| ORIC | Oric Pharmaceuticals | 6.76 | ||||
| GLUE | Monte Rosa | 6.45 | ||||
| INBX | Inhibrx | 5.19 | ||||
| DSGN | Design Therapeutics | 4.34 | ||||
| ERAS | Erasca | 3.67 | ||||
| LYRA | Lyra Therapeutics | 0 | ||||
| NXTC | NextCure | 0 | ||||
| SNSE | Sensei Biotherapeutics | 0 | ||||
| NUVB | Nuvation Bio | 0.37 | ||||
| EPIX | ESSA Pharma | 0.62 |
Check out Sentry Petroleum Hype Analysis, Sentry Petroleum Correlation and Sentry Petroleum Performance. To learn how to invest in Sentry Stock, please use our How to Invest in Sentry Petroleum guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sentry Petroleum. If investors know Sentry will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sentry Petroleum listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (1.10) | Return On Equity (1.84) |
The market value of Sentry Petroleum is measured differently than its book value, which is the value of Sentry that is recorded on the company's balance sheet. Investors also form their own opinion of Sentry Petroleum's value that differs from its market value or its book value, called intrinsic value, which is Sentry Petroleum's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sentry Petroleum's market value can be influenced by many factors that don't directly affect Sentry Petroleum's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sentry Petroleum's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sentry Petroleum is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sentry Petroleum's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.